TPG Capital Asia completes $203m acquisition of Healthscope's pathology business

Photo: Healthscope website

TPG Capital Asia has wrapped up its $202.7 million acquisition of Quest Laboratories, Healthscope’s pathology business in Asia. Healthscope is one of Australia’s leading healthcare providers, listed on the Australian Exchange (ASX).

TPG Asia Capital beat several private equity firms like Quadria Capital, EQT and lab testing company Eurofins to win this deal, according to reports. TPG Asia Capital is the Asian investment platform of American private equity giant, TPG.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter